How to Apply for the Accretion Nutraveda Limited IPO: Step-by-Step Investment Guide

     

    Accretion Nutraveda Limited is a healthcare-focused manufacturing company engaged in the production of ayurvedic and nutraceutical products across various dosage forms, including tablets, capsules, liquids, powders, oils, and external applications. Operating as a Contract Development and Manufacturing Organisation (CDMO), the company serves clients in domestic and select international markets. Its product portfolio covers multiple healthcare categories such as liver care, women’s health, bone and joint care, digestive care, respiratory care, cognitive support, paediatric nutrition, and skin and hair care. The company operates from a GMP-compliant manufacturing facility in Gujarat, supported by recognised quality and safety certifications, which enables it to undertake regulated manufacturing for different client requirements.

    To apply for the Accretion Nutraveda IPO, an investor needs an active Demat account, a trading account, and a bank account linked for online payments. The application can be submitted through the ASBA facility available on net banking platforms or via supported online trading applications. After selecting the IPO, investors need to enter the bid details and confirm the application. The amount remains blocked until the allotment process is completed, after which shares are credited to the Demat account if allotted.

    For more details, visit the Accretion Nutraveda Limited IPO page.

    Accretion Nutraveda Limited IPO Details and Objectives

    Details

    Information

    IPO Date

    January 27, 2026 to January 30, 2026

    Issue Size

    19,20,000 shares (agg. up to ₹25 Cr)

    Price Band

    ₹122 to ₹129 per share

    Lot Size

    1000 shares

    Listing At

    BSE SME

    Purpose of the IPO

    • Purchase of machineries for automation in company’s existing manufacturing unit

    • Purchase of machineries for a new manufacturing setup

    • Funding working capital requirements of the company

    • General corporate purposes

    Timeline of Accretion Nutraveda Limited IPO

    Event

    Date

    IPO Open Date

    Tue, Jan 27, 2026

    IPO Close Date

    Fri, Jan 30, 2026

    Tentative Allotment

    Mon, Feb 2, 2026

    Initiation of Refunds

    Tue, Feb 3, 2026

    Credit of Shares to Demat

    Tue, Feb 3, 2026

    Tentative Listing Date

    Wed, Feb 4, 2026

    Cut-off time for UPI mandate confirmation

    5 PM on Fri, Jan 30, 2026

    Pricing & Lot Size of Accretion Nutraveda Limited IPO

    Price Band for the IPO

    • ₹122 to ₹129 per share

    Minimum Lot Size and Application Details

    Application

    Lots

    Shares

    Amount

    Individual investors (Retail) (Min)

    2

    2,000

    ₹2,58,000

    Individual investors (Retail) (Max)

    2

    2,000

    ₹2,58,000

    S-HNI (Min)

    3

    3,000

    ₹3,87,000

    S-HNI (Max)

    7

    7,000

    ₹9,03,000

    B-HNI (Min)

    8

    8,000

    ₹10,32,000

    Accretion Nutraveda Limited IPO Application Process

    The Accretion Nutraveda Limited IPO application process can be completed online through your trading platform. Below is a step-by-step guide to applying for the IPO:

    Step 1: Login to Your Trading Platform

    Access your trading account using the broker's app or website.

    Step 2: Navigate to the IPO Section

    Go to the IPO section to view active IPO listings.

    Step 3: Select the Open IPO and Click Apply

    Locate Accretion Nutraveda Limited IPO in the list of available IPOs and click the ‘Apply’ button.

    Step 4: Enter the Quantity of Shares You Wish to Apply For

    Specify the number of shares (lot size: 1000 shares) within the price band of ₹122 to ₹129 per share.

    Step 5: Provide Your UPI ID

    Enter your UPI ID for payment authorisation and ensure sufficient funds in your bank account.

    Step 6: Confirm the Application

    Review your application details and confirm the UPI mandate before 5 PM on the last application day.

    Step 7: Complete the Process and Wait for Allotment

    Submit the application and monitor the allotment status to check if shares have been allocated to you.

    Shares Offered in Accretion Nutraveda IPO

    The allocation of shares in the Accretion Nutraveda IPO is structured across investor categories in line with applicable regulatory requirements. The issue provides defined reservations for qualified institutional buyers, non-institutional investors, and retail individual investors, with each category allotted a specified proportion of the net issue. This allocation framework outlines how the shares offered are distributed among different classes of investors.

    Investor Category

    Shares Offered

    Market Maker Shares Offered

    96,000 (5.00%)

    QIB Shares Offered

    9,08,000 (47.29%)

    NII (HNI) Shares Offered

    2,76,000 (14.37%)

    Retail Shares Offered

    6,40,000 (33.33%)

    Total Shares Offered

    19,20,000 (100.00%)

    This reservation structure reflects the categorisation and allocation approach disclosed for the issue, indicating the proportion of shares available to each investor segment.

    Financial Health and Performance

    Key Financial Metrics

    • Total Assets: Grew from ₹4.06 crore in FY23 to ₹10.86 crore as of March 2025.

    • Total income: Reached ₹16.06 crore in March 2025, as compared to ₹3.07 crore in FY23.

    • Profit After Tax (PAT): Stood at ₹2.61 crore for March 2025 as compared to ₹0.28 crore in FY23.

    • Net Worth: Recorded at ₹5.35 crore in March 2025 in comparison to ₹0.26 crore in FY23.

    • Reserves and surplus: Stood at ₹4.86 crore in March 2025, as compared to ₹-0.10 crore in FY23.

    • EBITDA: Stood at ₹3.65 crore in March 2025 in comparison to ₹0.59 crore in FY23.

    Recent Performance and Growth Prospects

    • The company has expanded its asset base over recent financial periods, reflecting a broader operational scale and increased business activity.

    • Income levels have shown steady improvement, indicating higher business volumes and wider client engagement across its manufacturing services.

    • Profitability has strengthened compared to earlier years, supported by improved utilisation of manufacturing capacity and operational efficiencies.

    • The company’s net worth has increased, mainly due to retained earnings and internal accruals generated from business operations.

    • Reserves and surplus have moved to a positive position, reflecting improved financial stability and better capital retention.

    • Operating performance has improved in line with higher production and sales activity, contributing to better cost absorption.

    • The overall financial trend indicates gradual strengthening of the balance sheet and operating profile, supported by expansion in manufacturing activities and client servicing.

    Investment Risks and Opportunities

    Potential Risks of Investing in the IPO

    • The company operates largely as a contract manufacturer, which may result in dependence on client orders and continued business relationships for revenue visibility.

    • Operations are concentrated in a single manufacturing facility, which may expose the business to operational disruptions arising from regulatory, logistical, or facility-related issues.

    Opportunities and Growth Potential

    • The planned use of IPO proceeds for automation and new manufacturing capacity may support expansion of production capabilities and wider client engagement over time.

    • The company’s presence across ayurvedic and nutraceutical segments, along with domestic and export markets, provides scope to cater to varied healthcare manufacturing requirements as demand for such products continues to evolve.

    Key Performance Indicator (KPI)

    KPI

    Mar 31, 2025

    ROE

    81.22%

    ROCE

    36.98%

    Debt/Equity

    0.72

    RoNW

    48.85%

    PAT Margin

    16.33%

    EBITDA Margin

    22.79%

    Price to Book Value

    8.76

    Accretion Nutraveda Limited IPO Registrar & Lead Managers

    Registrar

    Lead Manager(s)

    Kfin Technologies Ltd.

    Sobhagya Capital Options Pvt.Ltd.

    Company Address of Accretion Nutraveda Limited

    Accretion Nutraveda Ltd. 27 Xcelon Industrial Park-1 Vasna-Chacharwadi, TaSanand, Ahmedabad, Gujarat, 382213

    Phone: +91- 9904366177

    Email: compliance@accretionnutraveda.com

    Website: https://accretionnutraveda.com/

    Conclusion

    Accretion Nutraveda Limited operates as a contract manufacturer in the ayurvedic and nutraceutical segments, with a product portfolio covering multiple healthcare categories and manufacturing activities supported by recognised certifications. The IPO outlines defined objectives related to capacity expansion, automation, and working capital requirements, as disclosed in the offer details.

    The IPO application process follows a standard online route through ASBA or supported trading platforms and requires a Demat account with a linked bank account. Investors may review the issue schedule, pricing, allocation structure, and disclosed risks before submitting an application within the specified timeline.

    Interested in more opportunities? Check out our Upcoming IPO section for new listings and don’t forget to check your Accretion Nutraveda IPO allotment status.     

    Frequently Asked Questions

    Published Date : 27 Jan 2026

    Disclaimer :

    Investments in securities market are subject to market risk, read all related documents carefully before investing. This content is for educational purposes only. Securities quoted are exemplary and not recommendatory.


    The information on this website is provided on "AS IS" basis. Bajaj Broking (BFSL) does not warrant the accuracy of the information given herein, either expressly or impliedly, for any particular purpose and expressly disclaims any warranties of merchantability or suitability for any particular purpose. While BFSL strives to ensure accuracy, it does not guarantee the completeness, reliability, or timeliness of the information. Users are advised to independently verify details and stay updated with any changes. The securities are quoted as an example and not as a recommendation. Past performance is not necessarily a guide to future performance.

    The information provided on this website is for general informational purposes only and is subject to change without prior notice. BFSL shall not be responsible for any consequences arising from reliance on the information provided herein and shall not be held responsible for all or any actions that may subsequently result in any loss, damage and/or liability. Interest rates, fees, and charges etc., are revised from time to time, for the latest details please refer to our Pricing page.

    Neither the information, nor any opinion contained in this website constitutes a solicitation or offer by BFSL or its affiliates to buy or sell any securities, futures, options or other financial instruments or provide any investment advice or service.

    BFSL is acting as distributor for non-broking products/ services such as IPO, Mutual Fund, Insurance, PMS, and NPS. These are not Exchange Traded Products. For more details on risk factors, terms and conditions please read the sales brochure carefully before investing.



    Content Partner - Dalal Street Investment Journal Wealth Advisory Private Limited



    This article is for educational purposes only and should not be considered investment advice. Market investments are subject to risks. DSIJ Wealth Advisory Private Limited is a SEBI-registered Research Analyst (Reg. No: INH000006396) and Investment Adviser (Reg. No: INA000001142). Please consult your financial adviser before investing. 

    For more disclaimer, check here : https://www.bajajbroking.in/disclaimer

    Read More Blogs

    Our Secure Trading Platforms

    Level up your stock market experience: Scan the QR to download the Bajaj Broking App for effortless investing and trading

    QR code to download Bajaj Broking App

    1 M+ Users

    icon-with-text

    4.8 App Rating

    icon-with-text

    4 Languages

    icon-with-text

    ₹7,300 Cr+ MTF Book

    icon-with-text
    banner-icon

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |